Additional file 1 of Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma

Additional file 1: Supplementary Fig. 1. Schematic workflow for early detection and minimal residual disease monitoring of UC. Supplementary Fig. 2. Urine markers of UC. Supplementary Fig. 3. ROC curves of the RF and LR models in the training and test cohorts. Supplementary Fig. 4. Point boxplot of the utLIFE-UC score. Supplementary Fig. 5. Line chart of utLIFE-UC in continuous samples.